| Tomillero A, Moral MA
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 May; 31(4):263-98.
Abstract | Full Citation |
| Tomillero A, Moral MA
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 Apr; 31(3):183-227.
Abstract | Full Citation |
| Schöller-Gyüre M, Kakuda TN, Woodfall B, et al.
Effect of steady-state etravirine on the pharmacokinetics and pharmacodynamics of ethinylestradiol and norethindrone. [Journal Article, Research Support, Non-U.S. Gov't]
Contraception 2009 Jul; 80(1):44-52.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Brown KC, Paul S, Kashuba AD
Drug interactions with new and investigational antiretrovirals. [Journal Article]
Clin Pharmacokinet 2009; 48(4):211-41.
Abstract | Full Citation | Find Related Articles |
| Qi S, Weuts I, De Cort S, et al.
An investigation into the crystallisation behaviour of an amorphous cryomilled pharmaceutical material above and below the glass transition temperature. [JOURNAL ARTICLE]
J Pharm Sci 2009 Jun 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Kagan RM, Sista P, Pattery T, et al.
Additional HIV-1 mutation patterns associated with reduced phenotypic susceptibility to etravirine in clinical samples. [JOURNAL ARTICLE]
AIDS 2009 May 25.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Soria A, Porten K, Fampou-Toundji JC, et al.
Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients. [Journal Article]
Antivir Ther 2009; 14(3):339-47.
Abstract | Full Citation | Find Related Articles |
| Aboud M, Castelino S, Back D, et al.
Etravirine plasma levels in a patient with decompensated liver disease. [Letter]
AIDS 2009 Jun 19; 23(10):1293-5.
Full Citation | Publisher Full Text | Find Related Articles |
| Schiller DS, Youssef-Bessler M
Etravirine: A second-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) active against NNRTI-resistant strains of HIV. [Journal Article]
Clin Ther 2009 Apr; 31(4):692-704.
Abstract | Full Citation |
| Johnson & Johnson seeks full FDA approval for Intelence. [News]
AIDS Read 2009 Apr; 19(4):140.
Full Citation | Find Related Articles |
  |
